Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Roche snaps up Genia

Roche plans to incubate another novel DNA sequencing system. In June, the Swiss giant paid $125 million upfront and as much as $225 million in milestone fees to acquire Genia's semiconductor-based, single-molecule, nanopore technology. Genia will become part of Roche's sequencing division. This acquisition comes two years after Roche's failed attempt to buy sequencing powerhouse Illumina for $6.7 billion.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Roche snaps up Genia. Nat Biotechnol 32, 709 (2014). https://doi.org/10.1038/nbt0814-709a

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0814-709a

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing